Other Titles
Symposium: Omics-Based Research and Precision Healthcare Delivery Among Diverse and/or Underserved Populations Across the Lifespan
Abstract
Session presented on Thursday, July 21, 2016: Purpose: To better understand the impact of undergoing cardaic genetic testing, and the impact of clinically prescribed treatments in an underserved minority population. The objective of this investigation was to evaluate the psychological well-being and perceived cardiac risk among Dominicans who underwent clinically indicated cardiac genetic testing for a possible underlying inherited cardiomyopathy or inherited cardiac channelopathy that could result in a life threatening arrhythmia and/or sudden cardiac death. Methods: Participants completed the Short Form-36 (SF-36) questionnaire after undergoing cardiac genetic testing to evaluate the impact of cardiac genetic testing on their overall well-being and life choices and health decisions. Results: There were 51 subjects who underwent cardiac testing and a subsequent placement of an ICD for the prevention of sudden cardiac death. Participants revealed three common themes as part of their interviews: (a) fear of dying prematurely, (b) guilt of possibly passing on a mutation to their children, and (c) fear of having an implantable cardioverter defibrillator (ICD) shock. Physical components of the SF-36 were within normal limits but elevated for mental components. Those who suffered a cardiac event had the poorest quality of life as compared to those individuals who did not suffer a cardiac event and were referred for evaluation because of an abnormal echocardiogram, electrocardiogram or having a first degree family relative who was diagnosized with an inherited cardiac syndrome. Conclusion: Our findings are consistent with those reported in patients living with hypertrophic cardiomyopathy, where immediate and future concerns of a positive cardiac genetic diagnosis generates fear and concern for an individual with the illness and for other immediate family members who may be affected. However, from our clinical experiences and interviews, women (88%) feared passing on a mutation to their children, whereas male patients (82%) reported they feared the occurrence of a life-threatening arrhythmia or ICD firing. The quality of life and specific themes results in this study warrant further research in other populations undergoing genetic testing. Specifically, the impact of evolving genetic technology sin the clinical setting such as whole exon sequencing on future health outcomes and individual health choices is one area of future investigation.
Sigma Membership
Unknown
Type
Presentation
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
quality of life, minorities, genetics
Recommended Citation
Hickey, Kathleen, "Cardiac Genetic Testing in a Dominican Sample in New York" (2016). INRC (Congress). 20.
https://www.sigmarepository.org/inrc/2016/presentations_2016/20
Conference Name
27th International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Cape Town, South Africa
Conference Year
2016
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
Cardiac Genetic Testing in a Dominican Sample in New York
Cape Town, South Africa
Session presented on Thursday, July 21, 2016: Purpose: To better understand the impact of undergoing cardaic genetic testing, and the impact of clinically prescribed treatments in an underserved minority population. The objective of this investigation was to evaluate the psychological well-being and perceived cardiac risk among Dominicans who underwent clinically indicated cardiac genetic testing for a possible underlying inherited cardiomyopathy or inherited cardiac channelopathy that could result in a life threatening arrhythmia and/or sudden cardiac death. Methods: Participants completed the Short Form-36 (SF-36) questionnaire after undergoing cardiac genetic testing to evaluate the impact of cardiac genetic testing on their overall well-being and life choices and health decisions. Results: There were 51 subjects who underwent cardiac testing and a subsequent placement of an ICD for the prevention of sudden cardiac death. Participants revealed three common themes as part of their interviews: (a) fear of dying prematurely, (b) guilt of possibly passing on a mutation to their children, and (c) fear of having an implantable cardioverter defibrillator (ICD) shock. Physical components of the SF-36 were within normal limits but elevated for mental components. Those who suffered a cardiac event had the poorest quality of life as compared to those individuals who did not suffer a cardiac event and were referred for evaluation because of an abnormal echocardiogram, electrocardiogram or having a first degree family relative who was diagnosized with an inherited cardiac syndrome. Conclusion: Our findings are consistent with those reported in patients living with hypertrophic cardiomyopathy, where immediate and future concerns of a positive cardiac genetic diagnosis generates fear and concern for an individual with the illness and for other immediate family members who may be affected. However, from our clinical experiences and interviews, women (88%) feared passing on a mutation to their children, whereas male patients (82%) reported they feared the occurrence of a life-threatening arrhythmia or ICD firing. The quality of life and specific themes results in this study warrant further research in other populations undergoing genetic testing. Specifically, the impact of evolving genetic technology sin the clinical setting such as whole exon sequencing on future health outcomes and individual health choices is one area of future investigation.
